Echoliv
Paris
About Echoliv
Echoliv designs artificial intelligence solutions for abdominal ultrasound. They develop software to assist radiologists and hepatologists. The Ultraliv solution from Echoliv assists radiologists and hepatologists in early-stage ultrasound screening for the most common type of liver cancer, hepatocellular carcinoma (or HCC). The algorithm can detect nodules other than those identified by practitioners.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $230.4K
- Funding stage: Seed
- Last round: Pre-Seed (Jul 2022)
- Website: echoliv.ai
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Software
Social Profiles
Canonical: https://fsome.com/organization/echoliv-2214820 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.